Connection
Eric Wu to Diphosphonates
This is a "connection" page, showing publications Eric Wu has written about Diphosphonates.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.421 |
|
|
|
-
Wu EQ, Bensimon AG, Marynchenko M, Namjoshi M, Guo A, Yu AP, Ericson SG, Raje N. Comparison of skeletal complications and treatment patterns associated with early vs. delayed zoledronic acid therapy in multiple myeloma. Clin Lymphoma Myeloma Leuk. 2011 Aug; 11(4):326-35.
Score: 0.329
-
Xie J, Diener M, Sorg R, Wu EQ, Namjoshi M. Re.: Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States. J Med Econ. 2013; 16(2):260-2.
Score: 0.092